Meyers Michael L. is a director of Nuvalent Inc - Ordinary Shares.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Nuvalent, Inc.
16 Jun 23
4
Nuvalent, Inc.
6 Oct 22
3
Nuvalent, Inc.
6 Oct 22
4
Syndax Pharmaceuticals Inc
3 Feb 22
4
Syndax Pharmaceuticals Inc
3 Jan 22
4
Syndax Pharmaceuticals Inc
28 Apr 21
4
Syndax Pharmaceuticals Inc
5 Feb 21
4
Syndax Pharmaceuticals Inc
8 Jul 20
4
Syndax Pharmaceuticals Inc
14 Feb 20
4/A
Syndax Pharmaceuticals Inc
25 Mar 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | NUVL Nuvalent Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 44.68 | 15,000 | 670.20 k | 15,000 |